MARTIN HEIDECKER

Profile

First Name

: MARTIN

Middle Name

:

Last Name

: HEIDECKER

Related Companies
Titles
Company Name
Related People
DIRECTOR
ARMAGEN TECHNOLOGIES INC
RUBEN BOADO, RUBEN J. BOADO, WILLIAM PARDRIDGE, JAYSON PUNWANI, MATHIAS SCHMIDT, STUART SWIEDLER, ARTHUR TZIANABOS
DIRECTOR
SENTIEN BIOTECHNOLOGIES, INC.
GREG BAILEY, RICH GANZ, BRIAN MILLER, BIJU PAREKKADAN
DIRECTOR
TILOS THERAPEUTICS, INC.
JOHN EDWARDS, BARBARA FOX, ROGER KITTERMAN, JULIUS KNOWLES
DIRECTOR
ABEXXA BIOLOGICS, INC.
DEBRA WEIDANZ, JON WEIDANZ
DIRECTOR
ARMAGEN, INC.
RUBEN BOADO, RUBEN J. BOADO, WILLIAM PARDRIDGE, JAYSON PUNWANI, MATHIAS SCHMIDT, STUART SWIEDLER, ARTHUR TZIANABOS
DIRECTOR
RGENTA THERAPEUTICS, INC.
JUDITH LI, SUN LINGHAO, HONGBO LU, DEBASISH ROYCHOWDHURY, FEI SHEN, TRAVIS WAGER, ZHIPING WENG, HUALIN SIMON XI
DIRECTOR
VENATORX PHARMACEUTICALS, INC.
CHRISTOPHER J BURNS, CHRISTOPHER J. BURNS, SHELLEY CHU, MICHAEL DIEM, EZRA FELKER, TIMOTHY HAINES, TIM HENKEL, TIMOTHY J. HENKEL, TOMAS HEYMAN, ANTHONY MEEHAN, VINCENT J. MILANO, JAMES MURPHY, SERGEI PETUKHOV, DANIEL C PEVEAR, DANIEL C. PEVEAR, CARLO RIZZUTO, LUIGI XERRI
DIRECTOR
VEDANTA BIOSCIENCES, INC.
BHARATT CHOWRIRA, DANIEL COUTO, SUSAN DILLON, TROY IGNELZI, CURT LABELLE, JOHN LAMATTINA, JOHN L LAMATTINA, JOHN L. LAMATTINA, MARK MULLIKIN, BERNAT OLLE, BENNETT SHAPIRO, BENNETT M SHAPIRO, BENNETT M. SHAPIRO, CHARLES SHERWOOD, JEFFREY SILBER, NEIL TIWARI, CHRISTOPHER VIEHBACHER
DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.
SUBHENDU BASU, JESSE GOODMAN, IAN HARDY, JANA JENSEN, JONATHAN LEFF, EVAN LOH, RAYMOND MARTZ, RAYMOND L. MARTZ, CARL MERRIL, CARL R. MERRIL, GREGORY MERRIL, GREGORY L. MERRIL, GREGORY LOUIS MERRIL, WILLIAM MUTRYN, MICHAEL ORNDORFF
DIRECTOR
ELION THERAPEUTICS, INC.
JIM FLYNN, JONATHAN LEFF, KIEREN MARR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-08-05
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-03-01 
2024-06-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-11 
2023-07-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2023-02-17 
2023-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-25 
2023-05-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-03-01 
2023-02-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2023-02-17 
2022-12-22
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-19 
2022-09-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-19 
2022-04-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-18 
2021-03-12
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-21 
2020-02-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-21 
2018-03-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-23 
2017-09-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-13 
2016-09-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-07 
2016-09-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-19 
2015-08-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-05 
2012-11-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-13